Company: CL
Filing Date: 2025-04-25
Form Type: 10-Q
Source: 0000021665-25-000020
Chunk: 4

Company: COLGATE PALMOLIVE CO
Filing Date: 2025-04-25
Form: 10-Q
Item: Part II, Item 2
Chunk 4
---
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Shares repurchased from January 1, 2025 through March 20, 2025 were repurchased pursuant to a program approved by the Board of Directors (the “ Board”) on March 10, 2022 (the “2022 Program”). On March 20, 2025, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2025 Program”), which replaced the 2022 Program. The Company commenced the repurchase of shares of the Company’s common stock under the 2025 Program beginning March 21, 2025. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the stock repurchase activity for the three months in the quarter ended March 31, 2025:

  Month                            Total Number of Shares Purchased (1)                     Average Price Paid per Share      Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)                     Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (3)  
                                                                                                                                                                                                                                       (in millions)                                                                                 
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  January 1 through 31, 2025                                                 1,142,716                            $88.46                                                                                                1,139,000      $                                                                                             
  February 1 through 28, 2025                                                1,089,982                            $87.50                                                                                                  890,967      $                                                                                             
  March 1 through 31, 2025                                                     952,068                            $91.50                                                                                                  945,800      $                                                                                             
  Total                                                                      3,184,766                            $89.04                                                                                                2,975,767                                                                                                    

(1) Includes share repurchases under the 2022 Program and the 2025 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.

(2) The difference